Truepill Exit Candidate
π¦ Potential exit path:
SPAC, IPO

Select partners: Oscar Health, Cerebral, Levels, American Airlines, United Airlines, SimpleHealth, Hims & Hers, Humana, GoodRx.
Funding π°
Total
π¦ $255.4M
Select investors Optum Ventures, Oak HC/FT, Kaiser Permanente, Initialized Capital, TI Platform Management, Sound Ventures, Y Combinator
Key people π§βπ€βπ§
- Umar Afridi - Co-founder & CEO
- Sid Viswanathan - Co-Founder & President
- Sarah Butler - President, Life Sciences
- Lauren Lisher - President, Provider
- Chase Zaputil - President, Payers
Highlights β
- Truepill works with many of the world's largest healthcare organizations - from health plans and health providers, to pharma manufacturers. π
- Since the company's founding in 2016, Truepill has seen exponential demand for its consumer healthcare platform. When COVID-19 fundamentally disrupted the healthcare industry, the need for digital experiences soared and Truepillβs growth accelerated at an unprecedented rate. π
- In 2019, Truepill was featured in the Forbes "Next Billion-Dollar Startup" list. π
- During 2021, the company has shipped nearly 10 million prescriptions, processed nearly one million diagnostic tests and facilitated over 50,000 telehealth visits per week.
- "Truepill's technology has enabled a broad range of companies with telehealth, diagnostics, and pharmacy fulfillment solutions to deliver the best quality care and reimagine how consumers experience healthcare. We are proud to support Truepill's mission to accelerate healthcare's much-needed digital transformation, allowing companies to build innovative, accessible healthcare programs that address inefficient systems across the entire industry." - Said Garry Tan, founder and managing partner at Initialized Capital π
Last update: December 28, 2021
Disclaimer: We can not guarantee that the information on this page is 100% correct. more